observed in tumor-bearing mice a correlation between the severity of immune-induced colitis and the increased number of ILC3s in their intestinal mucosa, regardless of ILC1 and ILC2; reduction of the mucosal number of ILC3s improved the colitis symptoms, and the inflammatory indicators such as IL-17 showed a tendency to decrease to normalization (28). Here, IL17A is linked to colitis.